Consumer Health Neurology
Biocon Biologics Successfully Integrates Acquired Biosimilars Business Across 120 Countries
Biocon Biologics, a unique, fully integrated, global biosimilars company with a rich portfolio of insulins and monoclonal antibodies, has successfully conc...
December 19, 2023 | News
Merz Therapeutics Receives TGA Approval for XEOMIN® in Australia
This marks a significant milestone as XEOMIN® is the first approved neurotoxin for the treatment of this condition in the Australian market. Addit...
November 23, 2023 | News
Fujitsu Licenses Topological Data Analysis Tech to Bay Area Startup Delight Health for Mental Health Solutions
Fujitsu Limited and Delight Health, a Bay Area startup, announced that Fujitsu will license its Topological Data Analysis (TDA) technology to Delight...
November 20, 2023 | News
Aquinnah Pharmaceuticals Advances Alzheimer's Tauopathy Program
Aquinnah Pharmaceuticals announced preclinical research findings for a novel therapeutic designed to slow or stop the progression of Alzheimer's disea...
October 31, 2023 | News
Clario's Opal® Technology Drives Breakthrough in Parkinson's Disease at University of Oxford
Clario's Precision Motion Opal® wearable sensor technology detects early Parkinson's disease (PD) progression in a Univ...
October 30, 2023 | News
PharmaKure submits for Alzheimer's Disease Combined Drug Clinical Trial
PharmaKure, a clinical stage pharmaceutical company developing precision medicines for Alzheimer’s Disease and other neurodegenerative diseases...
October 25, 2023 | News
Rimegepant Now Available in Hong Kong as First Asian Market for Migraine Management
"As the first market in Asia, we are pleased to bring to Hong Kong this medication for migraine, as we understand how migraine can adversely...
October 02, 2023 | News
Bionomics Reports Positive Phase 2b Results for BNC210 in Post-Traumatic Stress Disorder Trial
ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks. St...
September 29, 2023 | News
Cellectricon expands neuroscience contract research portfolio with new Neuroplasticity services
Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, announced the launch of a new service module for neuroplasticit...
September 27, 2023 | News
Actinogen optimizes XanaMIA Phase 2b Alzheimer's disease trial design
Changes to the XanaMIA protocol reduce cost by AUD 30 million over the next two years and speed time to initial results while preserving the 36-week design...
September 27, 2023 | News
Ascletis Completes Enrollment for Glioblastoma Treatment Trial
Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces the completion of enrollment of 120 patients in the Phase III registration clinical trial of ...
September 27, 2023 | News
Cerecin strengthens position in neurometabolism with addition to pipeline
Cerecin completes in-licensing of an investigational radiolabelled tracer 18FBHB, CER-022, for development and use in positron emission tomography (...
September 20, 2023 | News
Oscotec/ADEL Receives FDA Clearance for Alzheimer's Treatment IND Application (ADEL-Y01)
Oscotec and ADEL are jointly developing a novel disease-modifying immunotherapy agent (ADEL-Y01) targeting tau protein accumulation in the AD brain. ADEL-Y...
September 15, 2023 | News
IBT and ATLATL Join Forces to Tackle Challenges in Brain Health
Starting out of China, IBT Global is a rising player in Digital Therapeutics (DTx) with an experienced cross-functional team operating at the intersection ...
September 05, 2023 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
